abobotulinumtoxinA
Otilonium may increase the anticholinergic activities of Botulinum Toxin Type A.
Aclidinium
Otilonium may increase the anticholinergic activities of Aclidinium.
Alfentanil
The risk or severity of adverse effects can be increased when Otilonium is combined with Alfentanil.
Advertisement
Alfuzosin
The risk or severity of hypotension can be increased when Alfuzosin is combined with Otilonium.
Alphaprodine
The risk or severity of adverse effects can be increased when Otilonium is combined with Alphaprodine.
Ambenonium
The therapeutic efficacy of Otilonium can be decreased when used in combination with Ambenonium.
Advertisement
Amobarbital
The metabolism of Otilonium can be increased when combined with Amobarbital.
Amorolfine
The therapeutic efficacy of Amorolfine can be increased when used in combination with Otilonium.
Amphotericin B
The therapeutic efficacy of Amphotericin B can be increased when used in combination with Otilonium.
Advertisement
amphotericin B liposomal
The therapeutic efficacy of Amphotericin B can be increased when used in combination with Otilonium.
Anidulafungin
The therapeutic efficacy of Anidulafungin can be increased when used in combination with Otilonium.
Artemether
The therapeutic efficacy of Artemether can be increased when used in combination with Otilonium.
Atracurium
The risk or severity of adverse effects can be increased when Atracurium is combined with Otilonium.
Atracurium Besylate
The risk or severity of adverse effects can be increased when Atracurium besylate is combined with Otilonium.
Atropine
The risk or severity of adverse effects can be increased when Atropine is combined with Otilonium.
Barbexaclone
The metabolism of Otilonium can be increased when combined with Barbexaclone.
Barbital
The metabolism of Otilonium can be increased when combined with Barbital.
Benactyzine
The risk or severity of adverse effects can be increased when Benactyzine is combined with Otilonium.
Bendroflumethiazide
The serum concentration of Bendroflumethiazide can be increased when it is combined with Otilonium.
Benzoic Acid
The therapeutic efficacy of Benzoic Acid can be increased when used in combination with Otilonium.
Benztropine
The risk or severity of adverse effects can be increased when Benzatropine is combined with Otilonium.
Bifonazole
The therapeutic efficacy of Bifonazole can be increased when used in combination with Otilonium.
Biperiden
The risk or severity of adverse effects can be increased when Biperiden is combined with Otilonium.
Botulinum Toxin Type A
Otilonium may increase the anticholinergic activities of Botulinum Toxin Type A.
Bunazosin
The risk or severity of hypotension can be increased when Bunazosin is combined with Otilonium.
Buprenorphine
The risk or severity of adverse effects can be increased when Otilonium is combined with Buprenorphine.
Butenafine
The therapeutic efficacy of Butenafine can be increased when used in combination with Otilonium.
Butoconazole
The therapeutic efficacy of Butoconazole can be increased when used in combination with Otilonium.
Butorphanol
The risk or severity of adverse effects can be increased when Otilonium is combined with Butorphanol.
Butylscopolamine
The risk or severity of adverse effects can be increased when Butylscopolamine is combined with Otilonium.
Calcium Acetate
The therapeutic efficacy of Otilonium can be decreased when used in combination with Calcium Acetate.
Calcium Chloride
The therapeutic efficacy of Otilonium can be decreased when used in combination with Calcium Chloride.
Calcium Chloride Anhydrous
The therapeutic efficacy of Otilonium can be decreased when used in combination with Calcium Chloride.
Calcium Citrate
The therapeutic efficacy of Otilonium can be decreased when used in combination with Calcium Citrate.
Calcium Glubionate
The therapeutic efficacy of Otilonium can be decreased when used in combination with Calcium glubionate.
Calcium gluceptate
The therapeutic efficacy of Otilonium can be decreased when used in combination with Calcium Gluceptate.
Calcium Gluconate
The therapeutic efficacy of Otilonium can be decreased when used in combination with Calcium gluconate.
Calcium Lactate
The therapeutic efficacy of Otilonium can be decreased when used in combination with Calcium lactate.
Carvedilol
The risk or severity of hypotension can be increased when Carvedilol is combined with Otilonium.
Casein Allergenic Extract
The therapeutic efficacy of Otilonium can be decreased when used in combination with Casein.
Caspofungin
The therapeutic efficacy of Caspofungin can be increased when used in combination with Otilonium.
Chlorothiazide
The serum concentration of Chlorothiazide can be increased when it is combined with Otilonium.
Chloroxine
The therapeutic efficacy of Chloroxine can be increased when used in combination with Otilonium.
Chlorphenoxamine
The risk or severity of adverse effects can be increased when Chlorphenoxamine is combined with Otilonium.
Chlorthalidone
The serum concentration of Chlorthalidone can be increased when it is combined with Otilonium.
Ciclopirox
The therapeutic efficacy of Ciclopirox can be increased when used in combination with Otilonium.
Cimetidine
The serum concentration of Otilonium can be increased when it is combined with Cimetidine.
Clopidogrel
The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Otilonium.
Clotrimazole
The therapeutic efficacy of Clotrimazole can be increased when used in combination with Otilonium.
Codeine
The risk or severity of adverse effects can be increased when Otilonium is combined with Codeine.
Codeine Anhydrous
The risk or severity of adverse effects can be increased when Otilonium is combined with Codeine.
CODEINE POLISTIREX
The risk or severity of adverse effects can be increased when Otilonium is combined with Codeine.
Cordycepin
The therapeutic efficacy of Cordycepin can be increased when used in combination with Otilonium.
Cyclopenthiazide
The serum concentration of Cyclopenthiazide can be increased when it is combined with Otilonium.
Cyclopentolate
The risk or severity of adverse effects can be increased when Cyclopentolate is combined with Otilonium.
Cyclosporine
The therapeutic efficacy of Cyclosporine can be increased when used in combination with Otilonium.
Darifenacin
The risk or severity of adverse effects can be increased when Darifenacin is combined with Otilonium.
Decanoic Acid
The therapeutic efficacy of Capric acid can be increased when used in combination with Otilonium.
Demecarium
The therapeutic efficacy of Otilonium can be decreased when used in combination with Demecarium.
Desloratadine
The risk or severity of adverse effects can be increased when Desloratadine is combined with Otilonium.
Dexetimide
The risk or severity of adverse effects can be increased when Dexetimide is combined with Otilonium.
Dextromoramide
The risk or severity of adverse effects can be increased when Otilonium is combined with Dextromoramide.
Dezocine
The risk or severity of adverse effects can be increased when Otilonium is combined with Dezocine.
Dicyclomine
The risk or severity of adverse effects can be increased when Dicyclomine is combined with Otilonium.
Dihydrocodeine
The risk or severity of adverse effects can be increased when Otilonium is combined with Dihydrocodeine.
Diphenoxylate
The risk or severity of adverse effects can be increased when Otilonium is combined with Diphenoxylate.
Distigmine
The therapeutic efficacy of Otilonium can be decreased when used in combination with Distigmine.
Donepezil
The therapeutic efficacy of Otilonium can be decreased when used in combination with Donepezil.
Doxazosin
The risk or severity of hypotension can be increased when Doxazosin is combined with Otilonium.
Echothiophate
The therapeutic efficacy of Otilonium can be decreased when used in combination with Echothiophate.
Econazole
The therapeutic efficacy of Econazole can be increased when used in combination with Otilonium.
Econazole Nitrate
The therapeutic efficacy of Econazole can be increased when used in combination with Otilonium.
Edrophonium
The therapeutic efficacy of Otilonium can be decreased when used in combination with Edrophonium.
Efavirenz
The serum concentration of Otilonium can be decreased when it is combined with Efavirenz.
Efinaconazole
The therapeutic efficacy of Efinaconazole can be increased when used in combination with Otilonium.
Eluxadoline
Otilonium may increase the constipating activities of Eluxadoline.
Ethylmorphine
The risk or severity of adverse effects can be increased when Otilonium is combined with Ethylmorphine.
Fentanyl
The risk or severity of adverse effects can be increased when Otilonium is combined with Fentanyl.
Fesoterodine
The risk or severity of adverse effects can be increased when Fesoterodine is combined with Otilonium.
Fluconazole
The therapeutic efficacy of Fluconazole can be increased when used in combination with Otilonium.
Flucytosine
The therapeutic efficacy of Flucytosine can be increased when used in combination with Otilonium.
Galantamine
The therapeutic efficacy of Otilonium can be decreased when used in combination with Galantamine.
Gallamine Triethiodide
The risk or severity of adverse effects can be increased when Gallamine Triethiodide is combined with Otilonium.
Ginkgo biloba extract
The therapeutic efficacy of Otilonium can be decreased when used in combination with Ginkgo biloba.
Glucagon
The risk or severity of adverse effects can be increased when Otilonium is combined with Glucagon recombinant.
glucagon (rDNA)
The risk or severity of adverse effects can be increased when Otilonium is combined with Glucagon recombinant.
Glycopyrronium
Otilonium may increase the anticholinergic activities of Glycopyrronium.
Glyphosate
The therapeutic efficacy of Glyphosate can be increased when used in combination with Otilonium.
Griseofulvin
The therapeutic efficacy of Griseofulvin can be increased when used in combination with Otilonium.
Griseofulvin microsize
The therapeutic efficacy of Griseofulvin can be increased when used in combination with Otilonium.
Haloprogin
The therapeutic efficacy of Haloprogin can be increased when used in combination with Otilonium.
Heroin
The risk or severity of adverse effects can be increased when Otilonium is combined with Heroin.
Hexetidine
The therapeutic efficacy of Hexetidine can be increased when used in combination with Otilonium.
Hexobarbital
The metabolism of Otilonium can be increased when combined with Hexobarbital.
Homatropine
The risk or severity of adverse effects can be increased when Otilonium is combined with Homatropine.
Human Secretin
The therapeutic efficacy of Human secretin can be decreased when used in combination with Otilonium.
Hydrochlorothiazide
The serum concentration of Hydrochlorothiazide can be increased when it is combined with Otilonium.
Hydrocodone
The risk or severity of adverse effects can be increased when Otilonium is combined with Hydrocodone.
HYDROCODONE POLISTIREX
The risk or severity of adverse effects can be increased when Otilonium is combined with Hydrocodone.
Hydroflumethiazide
The serum concentration of Hydroflumethiazide can be increased when it is combined with Otilonium.
Hydromorphone
The risk or severity of adverse effects can be increased when Otilonium is combined with Hydromorphone.
Hyoscyamine
The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Otilonium.
incobotulinumtoxinA
Otilonium may increase the anticholinergic activities of Botulinum Toxin Type A.
Indapamide
The serum concentration of Indapamide can be increased when it is combined with Otilonium.
Indoramin
The risk or severity of hypotension can be increased when Indoramin is combined with Otilonium.
Ipratropium Bromide
The risk or severity of adverse effects can be increased when Ipratropium bromide is combined with Otilonium.
Ipratropium Bromide Anhydrous
The risk or severity of adverse effects can be increased when Ipratropium bromide is combined with Otilonium.
Isoconazole
The therapeutic efficacy of Isoconazole can be increased when used in combination with Otilonium.
Isoflurophate
The therapeutic efficacy of Otilonium can be decreased when used in combination with Isoflurophate.
Itraconazole
The therapeutic efficacy of Itraconazole can be increased when used in combination with Otilonium.
Ketoconazole
The therapeutic efficacy of Ketoconazole can be increased when used in combination with Otilonium.
Labetalol
The risk or severity of hypotension can be increased when Labetalol is combined with Otilonium.
Levomethadyl
The risk or severity of adverse effects can be increased when Otilonium is combined with Levomethadyl Acetate.
Levorphanol
The risk or severity of adverse effects can be increased when Otilonium is combined with Levorphanol.
Magnesium Hydroxide
The risk or severity of hypotension and neuromuscular blockade can be increased when Otilonium is combined with Magnesium hydroxide.
Magnesium Oxide
The risk or severity of hypotension and neuromuscular blockade can be increased when Otilonium is combined with Magnesium oxide.
Magnesium Salicylate
The risk or severity of hypotension and neuromuscular blockade can be increased when Otilonium is combined with Magnesium salicylate.
Magnesium Sulfate
The risk or severity of hypotension and neuromuscular blockade can be increased when Otilonium is combined with Magnesium sulfate.
MAGNESIUM SULFATE ANHYDROUS
The risk or severity of hypotension and neuromuscular blockade can be increased when Otilonium is combined with Magnesium sulfate.
Malathion
The therapeutic efficacy of Otilonium can be decreased when used in combination with Malathion.
Mecamylamine
The risk or severity of adverse effects can be increased when Mecamylamine is combined with Otilonium.
Mefloquine
The therapeutic efficacy of Otilonium can be decreased when used in combination with Mefloquine.
Memantine
The therapeutic efficacy of Otilonium can be decreased when used in combination with Memantine.
Meperidine
The risk or severity of adverse effects can be increased when Otilonium is combined with Pethidine.
Mephobarbital
The metabolism of Otilonium can be increased when combined with Methylphenobarbital.
Methadone
The risk or severity of adverse effects can be increased when Otilonium is combined with Methadone.
Methadyl Acetate
The risk or severity of adverse effects can be increased when Otilonium is combined with Methadyl Acetate.
Methantheline
The risk or severity of adverse effects can be increased when Methantheline is combined with Otilonium.
Methixene
The risk or severity of adverse effects can be increased when Otilonium is combined with Metixene.
Methohexital
The metabolism of Otilonium can be increased when combined with Methohexital.
Methscopolamine
The risk or severity of adverse effects can be increased when Otilonium is combined with Methscopolamine.
Methscopolamine Bromide
The risk or severity of adverse effects can be increased when Otilonium is combined with Methylscopolamine bromide.
Methyclothiazide
The serum concentration of Methyclothiazide can be increased when it is combined with Otilonium.
Metoclopramide
The therapeutic efficacy of Otilonium can be decreased when used in combination with Metoclopramide.
Metolazone
The serum concentration of Metolazone can be increased when it is combined with Otilonium.
Mianserin
Mianserin may increase the anticholinergic activities of Otilonium.
Micafungin
The therapeutic efficacy of Micafungin can be increased when used in combination with Otilonium.
Miconazole
The therapeutic efficacy of Miconazole can be increased when used in combination with Otilonium.
Miltefosine
The therapeutic efficacy of Miltefosine can be increased when used in combination with Otilonium.
Minaprine
The therapeutic efficacy of Otilonium can be decreased when used in combination with Minaprine.
Mirabegron
The risk or severity of adverse effects can be increased when Otilonium is combined with Mirabegron.
Morphine
The risk or severity of adverse effects can be increased when Otilonium is combined with Morphine.
Nabilone
Otilonium may increase the tachycardic activities of Nabilone.
Nafcillin
The therapeutic efficacy of Otilonium can be decreased when used in combination with Nafcillin.
Naftifine
The therapeutic efficacy of Naftifine can be increased when used in combination with Otilonium.
Nalbuphine
The risk or severity of adverse effects can be increased when Otilonium is combined with Nalbuphine.
Natamycin
The therapeutic efficacy of Natamycin can be increased when used in combination with Otilonium.
Neostigmine
The therapeutic efficacy of Otilonium can be decreased when used in combination with Neostigmine.
Nitroprusside
Otilonium may increase the hypotensive activities of Nitroprusside.
Nitroxoline
The therapeutic efficacy of Nitroxoline can be increased when used in combination with Otilonium.
Normethadone
The risk or severity of adverse effects can be increased when Otilonium is combined with Normethadone.
Nystatin
The therapeutic efficacy of Nystatin can be increased when used in combination with Otilonium.
O-PHENANTHROLINE
The therapeutic efficacy of Otilonium can be decreased when used in combination with 1,10-Phenanthroline.
Octotropine Methylbromide
The risk or severity of adverse effects can be increased when Anisotropine Methylbromide is combined with Otilonium.
onabotulinumtoxinA
Otilonium may increase the anticholinergic activities of Botulinum Toxin Type A.
Opium
The risk or severity of adverse effects can be increased when Otilonium is combined with Opium.
Orphenadrine
The risk or severity of adverse effects can be increased when Orphenadrine is combined with Otilonium.
Oxiconazole
The therapeutic efficacy of Oxiconazole can be increased when used in combination with Otilonium.
Oxitropium
The risk or severity of adverse effects can be increased when Otilonium is combined with Oxitropium.
Oxybutynin
The risk or severity of adverse effects can be increased when Oxybutynin is combined with Otilonium.
Oxycodone
The risk or severity of adverse effects can be increased when Otilonium is combined with Oxycodone.
Oxymorphone
The risk or severity of adverse effects can be increased when Otilonium is combined with Oxymorphone.
Oxyphenonium
The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Otilonium.
Pafuramidine
The therapeutic efficacy of Pafuramidine can be increased when used in combination with Otilonium.
Pancuronium
The risk or severity of adverse effects can be increased when Pancuronium is combined with Otilonium.
Pancuronium Bromide
The risk or severity of adverse effects can be increased when Pancuronium is combined with Otilonium.
Paregoric
The risk or severity of adverse effects can be increased when Otilonium is combined with Morphine.
Pentamidine
The therapeutic efficacy of Pentamidine can be increased when used in combination with Otilonium.
Pentazocine
The risk or severity of adverse effects can be increased when Otilonium is combined with Pentazocine.
Pentobarbital
The metabolism of Otilonium can be increased when combined with Pentobarbital.
Phenobarbital
The metabolism of Otilonium can be increased when combined with Phenobarbital.
Physostigmine
The therapeutic efficacy of Otilonium can be decreased when used in combination with Physostigmine.
Pipecuronium
The risk or severity of adverse effects can be increased when Pipecuronium is combined with Otilonium.
Pirenzepine
The risk or severity of adverse effects can be increased when Pirenzepine is combined with Otilonium.
Pirinitramide
The risk or severity of adverse effects can be increased when Otilonium is combined with Piritramide.
Polythiazide
The serum concentration of Polythiazide can be increased when it is combined with Otilonium.
Posaconazole
The therapeutic efficacy of Posaconazole can be increased when used in combination with Otilonium.
Potassium Chloride
Otilonium may increase the ulcerogenic activities of Potassium Chloride.
Pramlintide
Pramlintide may increase the anticholinergic activities of Otilonium.
Prazosin
The risk or severity of hypotension can be increased when Prazosin is combined with Otilonium.
Primidone
The metabolism of Otilonium can be increased when combined with Primidone.
Procyclidine
The risk or severity of adverse effects can be increased when Procyclidine is combined with Otilonium.
Profenamine
The risk or severity of adverse effects can be increased when Ethopropazine is combined with Otilonium.
Propantheline
The risk or severity of adverse effects can be increased when Propantheline is combined with Otilonium.
Propantheline Bromide
The risk or severity of adverse effects can be increased when Propantheline is combined with Otilonium.
Propiverine
The risk or severity of adverse effects can be increased when Propiverine is combined with Otilonium.
Propoxyphene
The risk or severity of adverse effects can be increased when Otilonium is combined with Dextropropoxyphene.
Pyridostigmine
The therapeutic efficacy of Otilonium can be decreased when used in combination with Pyridostigmine.
Pyridostigmine Bromide
The therapeutic efficacy of Otilonium can be decreased when used in combination with Pyridostigmine.
Quinethazone
The serum concentration of Quinethazone can be increased when it is combined with Otilonium.
Quinidine
The risk or severity of adverse effects can be increased when Quinidine is combined with Otilonium.
Remifentanil
The risk or severity of adverse effects can be increased when Otilonium is combined with Remifentanil.
Rifabutin
The risk or severity of hypotension can be increased when Rifabutin is combined with Otilonium.
Rifampin
The risk or severity of hypotension can be increased when Rifampicin is combined with Otilonium.
Rifapentine
The risk or severity of hypotension can be increased when Rifapentine is combined with Otilonium.
Rifaximin
The risk or severity of hypotension can be increased when Rifaximin is combined with Otilonium.
rimabotulinumtoxinB
Otilonium may increase the anticholinergic activities of Botulinum Toxin Type B.
Rivastigmine
The therapeutic efficacy of Otilonium can be decreased when used in combination with Rivastigmine.
Salicylic Acid
The therapeutic efficacy of Salicylic acid can be increased when used in combination with Otilonium.
Scopolamine
The risk or severity of adverse effects can be increased when Scopolamine is combined with Otilonium.
Scopolamine Hydrobromide
The risk or severity of adverse effects can be increased when Scopolamine is combined with Otilonium.
Secobarbital
The metabolism of Otilonium can be increased when combined with Secobarbital.
Secretin
The therapeutic efficacy of Secretin can be decreased when used in combination with Otilonium.
Sertaconazole
The therapeutic efficacy of Sertaconazole can be increased when used in combination with Otilonium.
Silodosin
The risk or severity of hypotension can be increased when Silodosin is combined with Otilonium.
Sirolimus
The therapeutic efficacy of Sirolimus can be increased when used in combination with Otilonium.
Solifenacin
The risk or severity of adverse effects can be increased when Solifenacin is combined with Otilonium.
Sufentanil
The risk or severity of adverse effects can be increased when Otilonium is combined with Sufentanil.
Sulconazole
The therapeutic efficacy of Sulconazole can be increased when used in combination with Otilonium.
Sulpiride
Otilonium may increase the anticholinergic activities of Sulpiride.
Tacrine
The therapeutic efficacy of Otilonium can be decreased when used in combination with Tacrine.
Tamsulosin
The risk or severity of hypotension can be increased when Tamsulosin is combined with Otilonium.
Tapentadol
The risk or severity of adverse effects can be increased when Otilonium is combined with Tapentadol.
Tavaborole
The therapeutic efficacy of Tavaborole can be increased when used in combination with Otilonium.
Terazosin
The risk or severity of hypotension can be increased when Terazosin is combined with Otilonium.
Terbinafine
The therapeutic efficacy of Terbinafine can be increased when used in combination with Otilonium.
Terconazole
The therapeutic efficacy of Terconazole can be increased when used in combination with Otilonium.
Tetrahydrocannabinol
Otilonium may increase the tachycardic activities of Dronabinol.
Thiamylal
The metabolism of Otilonium can be increased when combined with Thiamylal.
Thiopental
The metabolism of Otilonium can be increased when combined with Thiopental.
Thiopental Sodium
The metabolism of Otilonium can be increased when combined with Thiopental.
Thymol
The therapeutic efficacy of Thymol can be increased when used in combination with Otilonium.
Tioconazole
The therapeutic efficacy of Tioconazole can be increased when used in combination with Otilonium.
Tiotropium
Otilonium may increase the anticholinergic activities of Tiotropium.
Tolnaftate
The therapeutic efficacy of Tolnaftate can be increased when used in combination with Otilonium.
Tolterodine
The risk or severity of adverse effects can be increased when Tolterodine is combined with Otilonium.
Topiramate
The risk or severity of adverse effects can be increased when Otilonium is combined with Topiramate.
Tramadol
The risk or severity of adverse effects can be increased when Otilonium is combined with Tramadol.
Tricalcium Phosphate
The therapeutic efficacy of Otilonium can be decreased when used in combination with Calcium Phosphate.
Trichlormethiazide
The serum concentration of Trichlormethiazide can be increased when it is combined with Otilonium.
Trihexyphenidyl
The risk or severity of adverse effects can be increased when Trihexyphenidyl is combined with Otilonium.
Trihexyphenidyl Hydrochloride
The risk or severity of adverse effects can be increased when Trihexyphenidyl is combined with Otilonium.
Trimethaphan
The risk or severity of adverse effects can be increased when Trimethaphan is combined with Otilonium.
Trimetrexate
The therapeutic efficacy of Trimetrexate can be increased when used in combination with Otilonium.
Tropicamide
The risk or severity of adverse effects can be increased when Tropicamide is combined with Otilonium.
Trospium
The risk or severity of adverse effects can be increased when Trospium is combined with Otilonium.
Tubocurarine
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Otilonium.
Umeclidinium
Otilonium may increase the anticholinergic activities of Umeclidinium.
Urapidil
The risk or severity of hypotension can be increased when Urapidil is combined with Otilonium.
Vecuronium
The risk or severity of adverse effects can be increased when Vecuronium is combined with Otilonium.
Voriconazole
The therapeutic efficacy of Voriconazole can be increased when used in combination with Otilonium.
